Quarterly report pursuant to Section 13 or 15(d)

Organization and Nature of Business (Details)

v3.23.1
Organization and Nature of Business (Details)
3 Months Ended
Sep. 19, 2022
USD ($)
$ / shares
shares
Mar. 31, 2023
USD ($)
segment
Mar. 31, 2022
USD ($)
Dec. 31, 2022
USD ($)
Sep. 30, 2022
$ / shares
shares
Dec. 31, 2021
shares
Dec. 21, 2021
$ / shares
Subsidiary, Sale of Stock [Line Items]              
Number of operating segments | segment   1          
Share price | $ / shares $ 0.50            
Gross proceeds $ 5,000,000.0            
Net proceeds $ 4,490,605            
Warrants to purchase shares | shares 500,000       500,000 172,500  
Warrants exercise price | $ / shares $ 0.625       $ 0.625   $ 12.50
Warrants exercise price percentage of IPO Price 125.00%            
Net loss   $ 1,516,864 $ 3,960,308        
Net cash used in operating activities   1,698,450 $ 2,656,017        
Accumulated deficit   $ 57,690,071   $ 56,173,207      
IPO | Maximum              
Subsidiary, Sale of Stock [Line Items]              
Shares issued | shares 10,000,000